Penumbra Inc
NYSE:PEN
| Market Cap (Intraday) | 10.70B |
| Current PE | N/A |
| Forward PE | 311.6 |
| 2yr Forward PE | 175.63 |
| 10-Day MA | $274.49 |
| 50-Day MA | $272.03 |
| 200-Day MA | $242.34 |
Penumbra Inc Stock, NYSE:PEN
One Penumbra Place, Alameda, California 94502
United States of America
Phone: +1.510.748.3200
Number of Employees: 3300
Description
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.